ViroSpot microneutralization assay for antigenic characterization of human influenza viruses

Smith, 2004, Mapping the antigenic and genetic evolution of influenza virus, Science, 305, 371, 10.1126/science.1097211 van de Sandt, 2015, Influenza B viruses: not to be discounted, Future Microbiol, 10, 1447, 10.2217/fmb.15.65 Flannery, 2015, Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015, MMWR Morb Mortal Wkly Rep, 64, 10 Pebody, 2015, Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results, Euro Surveill, 20, 10.2807/1560-7917.ES.2015.20.36.30013 Skowronski, 2015, Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015, Euro Surveill, 20, 10.2807/1560-7917.ES2015.20.4.21022 Koel, 2013, Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution, Science, 342, 976, 10.1126/science.1244730 Lin, 2010, Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?, J Virol, 84, 6769, 10.1128/JVI.00458-10 Lin, 2015, Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses, Influenza Other Respir Viruses, 9, 331, 10.1111/irv.12333 WHO, 2015, Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season, Weekly Epidemiol Rec, 90, 545 Rowe, 1999, Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays, J Clin Microbiol, 37, 937, 10.1128/JCM.37.4.937-943.1999 WHO. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Geneva; 2011. van Baalen, 2014, Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture, J Clin Microbiol, 52, 1672, 10.1128/JCM.03575-13 Isaacs, 1952, Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1, Bull World Health Organ, 6, 287 Westgeest, 2015, Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses, J Virol Methods, 217, 55, 10.1016/j.jviromet.2015.02.014 Matrosovich, 2006, New low-viscosity overlay medium for viral plaque assays, Virol J, 3, 63, 10.1186/1743-422X-3-63 Chambers, 2015, Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014–2015 influenza season, Cell Rep, 12, 1, 10.1016/j.celrep.2015.06.005 Ampofo, 2015, Strengthening the influenza vaccine virus selection and development process: report of the 3rd WHO informal consultation for improving influenza vaccine virus selection held at WHO headquarters, Geneva, Switzerland, 1–3 April 2014, Vaccine, 33, 4368, 10.1016/j.vaccine.2015.06.090